Stay updated on Nivolumab in Type B3 Thymoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Type B3 Thymoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s footer/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a platform or UI release rather than a change to the study record.
    Difference
    0.0%
    Check dated 2026-04-24T05:40:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:26.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T22:53:34.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3 (the previous v3.4.2 tag was removed).
    Difference
    0.0%
    Check dated 2026-03-11T18:40:14.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is added, and the previous government-funding maintenance notice and the Revision: v3.4.1 entry have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:20:43.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A system notice about a lapse in government funding was added, and the page revision was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:34:16.000Z thumbnail image

Stay in the know with updates to Nivolumab in Type B3 Thymoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.